Altus Formulation Inc.: Altus Formulation Announces Allowance of New Flexitab Technology Patent in USA
Altus Formulation Inc.: Altus Formulation Announces Allowance of New Flexitab Technology Patent in USA New USA Patent Complements Existing Global Flexitab Portfolio LAVAL, QC / ACCESSWIRE / April 15, 2021 / Altus Formulation Inc. ("Altus") today announced that its patent application US 2020029785 covering all Flexitab Breakable Extended Release Tablets has been allowed by the United States Patent and Trademark Office. The new patent is expected to provide protection to Flexitab products in the USA until 2038. Speaking about the new patent Dr. Damon Smith CEO of Altus said; "We are very pleas...